How Often Should You Inject TRT

Most men on testosterone replacement therapy should inject testosterone cypionate or enanthate every 7-14 days for optimal hormone stability. The testosterone cypionate label allows 50 to 400 mg every two to four weeks, and the Endocrine Society's 2018 guideline lists 75 to 100 mg weekly or 150 to 200 mg every two weeks as standard regimens; no published study supports a single percentage of men who become stable on one schedule. The frequency depends on your specific testosterone ester, individual metabolism, and target blood levels. Testosterone cypionate's half-life is approximately eight days per its label, which is why weekly or twice-weekly dosing smooths the peaks and troughs; the on-therapy target is the middle of the normal range, which the AUA defines as 450 to 600 ng/dL. Some physicians prescribe bi-weekly injections to reduce injection burden, though this may cause hormone fluctuations in sensitive patients. Your doctor will adjust frequency based on your symptom response and blood work results taken at trough levels.

Standard TRT Injection Schedules by Testosterone Type

Testosterone cypionate and enanthate are the most commonly prescribed injectable esters in the United States, and their pharmacokinetics are similar. Both esters have half-lives of 7-8 days, making them suitable for weekly or bi-weekly injection protocols. Weekly injections of 75 to 100 mg keep blood levels more consistent; after a 200 mg intramuscular cypionate dose, levels peak around days 4 to 5 and fall back toward about 400 ng/dL by day 14 (Shoskes et al., 2016), with the trough just before the next dose. Testosterone propionate requires more frequent dosing every 2-3 days due to its 1.5-day half-life. While this creates very stable hormone levels, most patients prefer less frequent injections. Some clinics combine testosterone esters in custom formulations to extend dosing intervals while maintaining stability.

Factors That Determine Your Optimal Injection Frequency

Your individual testosterone metabolism rate significantly impacts injection frequency requirements. Men with faster metabolisms may need weekly injections even with long-acting esters, while others maintain stable levels with bi-weekly dosing. Age, SHBG and body composition all shift how a given dose reads on labs, but no published figure quantifies an age-related difference in clearance, and an earlier version of this article printed one that we could not source. Body weight and muscle mass affect testosterone distribution and clearance. Larger men often require higher doses but not necessarily more frequent injections. Your baseline testosterone production, SHBG levels, and liver function all influence how quickly you process injected testosterone. Some patients benefit from combining TRT with peptide therapy to optimize overall hormone function.

Monitoring Your TRT Schedule Effectiveness

Blood work timing determines whether your injection frequency is optimal. The Endocrine Society recommends measuring testosterone midway between injections for cypionate or enanthate and aiming for the mid-normal range; the AUA recommends adjusting the dose to the middle tertile of the reference range (450 to 600 ng/dL) and rechecking every 6 to 12 months. If a mid-interval or trough level sits below the reference range, a shorter interval or a higher dose is the usual fix, decided by your prescriber. Peak levels measured around days 4 to 5 after a cypionate injection help identify if doses are too high, potentially causing side effects. The goal is keeping levels in the mid-normal range across the dosing cycle; Alabama's medical board, for example, says a mid-interval level on injectables should not exceed 700 ng/dL and treats values above 800 ng/dL as excessive. Many patients also track subjective symptoms like energy, mood, and libido to fine-tune their schedules. Consider discussing Sermorelin therapy with your provider if you need additional support for recovery and hormone optimization.

Adjusting Injection Frequency Based on Results

Most TRT adjustments happen during the first 6 months of treatment as your body adapts to exogenous testosterone. If weekly injections cause excessive peak levels above 1000 ng/dL, splitting the dose into twice-weekly injections often resolves this issue. Some men prefer every 5-day cycles to maintain more consistent levels. Patient preference also matters significantly. Men who travel frequently may prefer bi-weekly injections despite slightly less stable levels. Others find that more frequent injections help with mood stability and energy consistency. Your healthcare provider should work with you to find a balance between clinical effectiveness and lifestyle compatibility.

Three dosing frameworks: the label, the guidelines and clinic practice

Injection frequency advice online mixes three sources that do not say the same thing. Keeping them apart makes it easier to understand what your prescriber is working from. Sources checked September 5, 2026.

Framework	Regimen	Target	Source
FDA label, testosterone cypionate injection	50 to 400 mg intramuscularly every two to four weeks for replacement in hypogonadal men	None stated; check hemoglobin and hematocrit periodically for polycythemia	DailyMed label, revised 01/2022
Endocrine Society clinical practice guideline (2018)	Testosterone enanthate or cypionate 150 to 200 mg intramuscularly every 2 weeks, or 75 to 100 mg weekly	Mid-normal range; measure midway between injections; hematocrit above 54 percent means withhold therapy	J Clin Endocrinol Metab 2018;103(5):1715
American Urological Association guideline (2018, validity confirmed 2024)	Not prescriptive about interval	Adjust dosing to the middle tertile of the normal reference range (450 to 600 ng/dL); measure every 6 to 12 months on therapy	AUA testosterone deficiency guideline
Clinic practice	Commonly 100 mg weekly, or the same weekly dose split into two injections; subcutaneous dosing is increasingly used	Varies by clinic	Choi et al., J Urol 2022 (measured); clinic websites (unmeasured)

The label interval of every two to four weeks is legal and common, but the guideline regimens are shorter because a 200 mg dose every two weeks produces a supraphysiologic peak followed by a low trough. That is the next section.

Why interval matters: the peak and trough numbers

The case for weekly or twice-weekly dosing rests on measured pharmacokinetics, not preference.

Measurement	Value	Source
Half-life of testosterone cypionate, intramuscular	Approximately eight days	Testosterone cypionate label (DailyMed, revised 01/2022)
Peak after 200 mg intramuscular cypionate	Mean 1,112 plus or minus 297 ng/dL at days 4 to 5, a supratherapeutic level	Shoskes et al., Transl Androl Urol 2016 (PMC5182226)
Level by day 14 after the same dose	Falls toward about 400 ng/dL	Shoskes et al., 2016
Physiologic target used in that review	400 to 700 ng/dL	Shoskes et al., 2016
Regulator's ceiling for a mid-interval injectable level	Should not exceed 700 ng/dL; above 800 ng/dL considered excessive	Alabama Board of Medical Examiners TRT guidelines, approved February 20, 2025
Other injectable schedules for comparison	Testosterone undecanoate 750 mg at weeks 0 and 4, then every 10 weeks; pellets 150 to 450 mg every 3 to 6 months	Shoskes et al., 2016

Read together: a 200 mg dose every two weeks swings a man from above 1,100 ng/dL to about 400 within the interval. Splitting the same total into 100 mg weekly, or 50 mg twice weekly, keeps both the peak and the trough closer to the middle of the range, which is what the AUA's 450 to 600 ng/dL target and Alabama's 700 ng/dL ceiling are asking for.

Once weekly versus twice weekly versus subcutaneous: what has been measured

Clinic blogs argue about split dosing with few numbers. One published comparison is worth knowing. Choi and colleagues (Journal of Urology, March 2022; PMID 34694927) followed 234 hypogonadal men treated with either intramuscular testosterone cypionate 100 mg weekly or subcutaneous testosterone enanthate 100 mg weekly by autoinjector for 12 weeks.

Regimen (100 mg weekly)	Trough total testosterone at baseline	Trough at 12 weeks
Intramuscular testosterone cypionate	313.6 ng/dL	536.4 ng/dL
Subcutaneous testosterone enanthate (autoinjector)	246.6 ng/dL	552.8 ng/dL

Both weekly regimens landed the trough in the middle of the normal range, which is the point. The study was framed around a concern with intramuscular cypionate: its supraphysiologic peaks are associated with rises in estradiol, hematocrit and PSA, and a flatter subcutaneous profile may limit those. No trial we could find measures a stability percentage for once-weekly versus twice-weekly dosing; an earlier version of this article quoted one, and it has been removed. The honest summary is that shorter intervals produce flatter curves, subcutaneous weekly dosing has published data behind it, and the right split for you is a prescriber decision based on your mid-interval labs and how you feel.

Monitoring targets and intervals

Injection frequency is only as good as the labs that check it. These are the monitoring rules in the label, the two U.S. guidelines and one state medical board's published standard.

Item	Rule	Source
When to draw the level	Midway between injections for enanthate or cypionate	Endocrine Society 2018
Target on therapy	Mid-normal range (Endocrine Society); middle tertile, 450 to 600 ng/dL (AUA)	Endocrine Society; AUA
Ceiling for injectables	Mid-interval level not above 700 ng/dL; above 800 ng/dL excessive	Alabama Board of Medical Examiners, February 20, 2025
How often to recheck	Every 6 to 12 months (AUA); labs every 6 months and an annual in-person visit (Alabama board)	AUA; Alabama board
Hematocrit	Check hemoglobin and hematocrit periodically (label); hematocrit above 54 percent defines erythrocytosis and therapy should be withheld (Endocrine Society)	Cypionate label; Endocrine Society

If your clinic draws labs only at the peak or only at the trough, ask why. A mid-interval draw is what the guideline asks for, and it is the number that tells you whether your interval, not just your dose, is right.

Frequently Asked Questions

How often should I inject testosterone cypionate?

The FDA label allows 50 to 400 mg every two to four weeks, but the Endocrine Society's 2018 guideline lists 75 to 100 mg weekly or 150 to 200 mg every two weeks, and many clinics use weekly or twice-weekly dosing to keep levels closer to the middle of the normal range. Your prescriber sets the interval from your mid-interval testosterone level, hematocrit and symptoms; changing it on your own is not advised.

Is twice a week better than once a week for TRT?

Splitting the same weekly dose into two injections produces smaller peaks and troughs, because cypionate's half-life is about eight days and a single large dose peaks around days 4 to 5 (Shoskes et al., 2016). Published trial data compare weekly intramuscular cypionate with weekly subcutaneous enanthate (Choi et al., 2022), both reaching mid-normal troughs; no study assigns a stability percentage to twice-weekly dosing. It is a reasonable option to discuss, not a proven upgrade.

What is the half-life of testosterone cypionate?

Approximately eight days when injected intramuscularly, according to the FDA-approved testosterone cypionate label (DailyMed, revised January 2022). In practice that means a 200 mg injection peaks around days 4 to 5 at a mean of about 1,112 ng/dL and falls toward 400 ng/dL by day 14 (Shoskes et al., 2016), which is why weekly or twice-weekly schedules flatten the curve compared with every-two-week dosing.

When should I get my testosterone level checked on injections?

The Endocrine Society recommends drawing the level midway between injections for cypionate or enanthate and aiming for the mid-normal range. The AUA recommends rechecking every 6 to 12 months and adjusting to the middle tertile of the reference range, about 450 to 600 ng/dL. Alabama's medical board requires labs every 6 months, says a mid-interval level should not exceed 700 ng/dL, and hematocrit should be checked at each visit.

Related guides

• HCG Injection Schedule on TRT: How Often to Inject
• Best TRT Injection Sites: Where to Inject Testosterone
• TRT Blood Work: What to Test and How Often
• How Often Do You Need TRT Injections?
• How Often to Get Blood Work on TRT
• When Should You Start TRT? Signs and Levels

Sources

1. Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364
2. Lakshman KM, Basaria S. Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging. 2009;4:397-412. PMID: 19915697
3. Snyder PJ, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. PMID: 26886521
4. Corona G, et al. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males. Andrology. 2020;8(5):970-987. PMID: 32333494
5. Salonia A, et al. EAU Guidelines on Sexual and Reproductive Health. European Association of Urology. 2023.
6. Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. PMID: 29601923
7. Hackett G, et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency. J Sex Med. 2017;14(12):1504-1523. PMID: 29198510
8. Testosterone cypionate injection prescribing information (Cipla), DailyMed, revised 01/2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78d55bad-4a5b-4e21-aeb8-a4c6346208be
9. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2018;103(5):1715-1744 (PMID 29562364). https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy-in-men-with-hypogonadism
10. American Urological Association. Evaluation and management of testosterone deficiency: AUA guideline, 2018, validity confirmed 2024. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
11. Shoskes JJ, Wilson MK, Spinner ML. Pharmacology of testosterone replacement therapy preparations. Transl Androl Urol 2016 (PMC5182226). https://pmc.ncbi.nlm.nih.gov/articles/PMC5182226/
12. Choi EJ, Xu P, El-Khatib FM, et al. Comparison of outcomes for hypogonadal men treated with intramuscular testosterone cypionate versus subcutaneous testosterone enanthate. J Urol 2022;207(3):677-683 (PMID 34694927). https://europepmc.org/article/MED/34694927
13. Alabama Board of Medical Examiners. Guidelines for testosterone replacement therapy in males, approved February 20, 2025. https://www.albme.gov/uploads/pdfs/TRT_GuidelinesMale.pdf